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Abstract 
COVID-19, a member of corona virus family is spreading its tentacles 
across the world due to lack of drugs at present. However, the main 
viral proteinase (Mpro/3CLpro) has recently been regarded as a 
suitable target for drug design against SARS infection due to its vital 
role in polyproteins processing necessary for coronavirus 
reproduction. The present in silico study was designed to evaluate 
the effect of Jensenone, a essential oil component from eucalyptus oil, 
on Mpro by docking study. In the present study, molecular docking 
studies were conducted by using 1-click dock and swiss dock tools. 
Protein interaction mode was calculated by Protein Interactions 
Calculator.The calculated parameters such as binding energy, and 
binding site similarity indicated effective binding of Jensenone to 
COVID-19 proteinase. Active site prediction further validated the 
role of active site residues in ligand binding. PIC results indicated 
that, Mpro/ Jensenone complexes forms hydrophobic interactions, 
hydrogen bond interactions and strong ionic interactions. Therefore, 
Jensenone may represent potential treatment potential to act as 
COVID-19 Mpro inhibitor. However, further research is necessary to 
investigate their potential medicinal use. 
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Introduction 
COVID-19 is easily transmissible and it has 
already been spread worldwide. Symptoms 
are flu-like and can include fever, muscle 
and body aches, coughing, and sore throat. 
Symptoms may appear 5-6 days after 
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infection. As of March 20h, 2020, over 
243,000 cases of COVID-19 have been 
confirmed worldwide, over 10,000 of which 
have resulted in death. At present, no 
specific therapies for COVID-19 are 
available and research regarding the 
treatment of COVID-19 are infancy. 
However, the measures that have been 
implemented remain limited to preventive 
and supportive therapies, designed to 
prevent further complications and organ 
damage [Morales et al., 2020]. Some 
preliminary studies have investigated 
potential combinations that include anti 
malarial drug chlorouinone, and anti-HIV 
vaccines can be used to treat COVID-19 
infections. A separate investigation 
performed by Lu (2020) indicated that 
among 4 tested drugs (nelfinavir, 
pitavastatin, perampanel, and praziquantel), 
nelfinavir was identified as the best 
potential inhibitor against COVID-19.  
The main protease (Mpro)/chymotrypsin-
like protease (3CLpro) from COVID-19, 
represents a potential target for the 
inhibition of CoV replication [Lu, 2020]. It 
was observed that genome of CoV encodes 
two proteins ppla and pplb which are 
involved in spike, membrane, envelop, 
nucleoprotein, replicase, and polymerase 
activity of viruses. This function is 
performed by main protease 
(Mpro/3CLpro) (Liu and Wang, 2020). The 
Mpro has 3 structural domains; domain I 
(residues 8 - 101) and domain II (residues 
102 - 184) both have beta barrel motifs 
representing chymotrypsin catalytic domain 
and domain III (residues 185 - 200) with a 
helical structure participates in dimerization 
of protein and active enzyme production. 
Given its vital role in polyprotein processing 
and virus maturation, Mpro is considered to 
be a suitable target for viral inhibitor 
development as an approach toward SARS. 
Environmental factors can greatly influence 
the secretion of secondary metabolites from 
aromatic plants. Therefore, great attention 
has been paid to the secondary metabolites 
secreted by plants that may be developed as 
medicines [Xang et al., 2018]. Among several 
compounds, essential oils, from medicinal 
plants, have been reported to have antiviral 
bioactivities [Zakaryan et al., 2017]. Essential 
oils are highly volatile substances in a 
mixture of terpenes, oxygenated derivatives 
and other aromatic compounds. Jensenone is 
the another component found in eucalyptus 
oil from all eucalyptus plants (Goodger et 
al., 2016). Jensenone is a natural organic 
compound that is a colorless liquid. It is a 
cyclic ether and a monoterpenoid. In the 
present study, we investigated Jensenone as 
potential inhibitor candidates for COVID-19 
Mpro. The findings of the present study will 
provide other researchers with opportunities 
to identify the right drug to combat COVID-
19. 
Material and methods 
Proteins/Macromolecules 
COVID-19 3CLpro/Mpro structures were 
obtained from PDB 
(https://www.rcsb.org/). The native ligand 
for 3clpro/Mpro structures was Jensenone. 
Ligand and Drug Scan 
The 3-dimensional (3D) structure of 
Jensenone was obtained from PubChem 
(https://pubchem.ncbi.nlm.nih.gov/). 
PubChem is a chemical substance and 
biological activities repository consisting of 
three databases, including substance, 
compound, and bioassay databases.  
Binding Mode of Docked Complexes  
The docked complex structure output 
format was submitted into the Protein 
Interactions Calculator (PIC) webserver 
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(http://pic.mbu.iisc .ernet.in/) in order to 
map the interaction of the resulting docked 
complex. The parameters such as number of 
hydrogen bonds, number of hydrophobic 
residues, and number of aromatic and ionic 
interactions were considered in interpreting 
the strength of the interaction 
Determination of Active Sites 
The amino acids in the active site of a 
protein were determined using the 
Computed Atlas for Surface Topography of 
Proteins (CASTp) 
(http://sts.bioe.uic.edu/castp/index.html?2
01l). 
Molecular Docking 
The docking study of the compound over 
COVID-19 Mpro was studied using 1-click 
docking (https://mcule.com/apps/1-click-
docking/) and swiss doc 
(http://www.swissdock.ch/ ) softwares.  
 
Table 1: Properties of COVID-19 Mpro potential inhibitor Jensenone 
Ligand Property Value 
 
Mass 266.2459 
 logP 1.6572 
H-bond acceptors 6 
H-bond donors 3 
Rotatable bonds 5 
PSA 111.9000 
RO5 violations 0 
RO3 violations 3 
Refractivity 67.9015 
Atoms 33 
Rings 1 
Heavy atoms 19 
Hydrogen atoms 14 
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Ligand Property Value 
Heteroatoms 6 
N/O atoms 6 
Inorganic atoms 0 
Halogen atoms 0 
Chiral centers 0 
R/S chiral centers 0 
Unknown chiral centers 0 
Undefined chiral centers 0 
Stereo double bonds 0 
Cis/trans stereo double bonds 0 
Unknown stereo double bonds 0 
 Undefined stereo double bonds 0 
 
Result and Discussion 
Computational and structural biology 
methods have accelerated the discovery of 
novel drugs used to treat viral diseases. 
Corona viruses (CoVs) are a group of 
viruses that infect animals and humans. CoV 
infections affect animals in various ways 
like: respiratory, fever, cold, digestive, and 
liver systems of humans and animals.  It is 
the main protease (Mpro) found in the CoV 
associated with the severe acute respiratory 
syndrome (SARS), which can be accessed in 
PDB and was suggested to be a potential 
drug target for 2019-nCov [Lu, 2020). In 
many viruses, proteases play essential roles 
in viral replication; therefore, proteases are 
often used as protein targets during the 
development of antiviral therapeutics. In 
CoV, the Mpro protein is involved in virus 
proteolytic maturation and has been 
examined as a potential target protein by 
inhibiting the cleavage of the viral 
polyprotein to prevent the spread of 
infection. The invention of the 
Mpro/3CLpro protease structure in COVID-
19 provides a nice path to identify potential 
drug candidates to prevent infection. As 
cited by Liu and Wang (2020), proteases 
represent key targets for the inhibition virus 
replication, and the protein sequences of the 
SARS-CoV Mpro and the 2019-nCoV Mpro 
are 96% identical, hence host proteases can 
be used as potential therapeutic targets. We 
followed the structural biology aspects 
which focus on the availability and retrieval 
of a main protease (Mpro) or 3C-like 
protease (3CLpro) receptor structure from 
PDB database. The ligand (Jensenone) was 
docked to main protease (Mpro) or 3C-like 
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protease (3CLpro) using 1-click and swiss 
dock softwares.  Table 1and 2 shows the 
structure of ligand and amino acids found in 
the active site pockets of Mpro.   
 
Table 2: Protein target structure, native ligand and active site amino acids 
Pdb id Macromolecule Native ligand Active site 
1UK3 
 
 
PHE18,LEU139,ASN140, 
GLY141,SER142,CYS143, 
PRO166 
 
Previously several ligands and drug 
candidate compounds have been selected, as 
per criteria of  Lipinski’s rule of five. So the 
ligands that did not incur more than 2 
violations of Lipinski’s rule could be used in 
molecular docking experiments with the 
target protein. The drug scanning results 
(Table 1) show that Jensenone, ligand used 
in this study, was accepted by Lipinski’s 
rule of five. 1-click docking tool that was 
used to find out interaction of inhibitor i.e 
Jensenone with Mpro/3CLpro protein 
revealed 4 different poses based on the dock 
score and the pose with highest negative 
values indicated maximum binding affinity 
(Table 3). The results of Swiss Dock are 
shown in Table 3. The results of Swiss Dock 
showed full fitness and Gibbs free energy 
predicts docking interactions. The Jensenone 
showed full fitness of-2290.07 kcal/mol and 
estimated ΔG of-6.03 kcal/mol within active 
site amino acids PHE138 and HIS161 of  
 
 
 
Table 3. Binding Energy and full fitness values of  Docked complex 
Inhibitor Dock pose Dock score (-) 
Jensenone 1 5.5 
 2 5.5 
 3 5.0 
 4 4.8 
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Mpro/3CLpro proteins of COVID-19 (Fig. 
1). Located at the interface between domains 
I and II, the 2 conserved residues His61 and 
PHE138 form the catalytic dyad of Mpro. 
CAST-P server also revealed the presence of 
PHE138 as active site residue of cavity 3 in 
Mpro protein (Table 1). Several compounds, 
such as flavonoids, terpenoids and phenolics 
from essential oils, have been reported to 
show antiviral bioactivities [Im et al., 2015; 
Zakarayan et al., 2017]. We investigated that 
jensenone as potential inhibitor of the 
COVID-19 Mpro.  Hydroxy groups (-OH), 
ketone groups (=O) and ether groups (-O-) 
in Jensenone compounds are predicted to 
play roles amino acid residue interactions at 
the active site of COVID-19 Mpro. 
Fig 1: Representation of docking of Jensenone with COVID-19 Mpro protein 
Once we observed that the Jensenone could 
potentially bind to Mpro/3CLpro protein, 
the next step was to know the binding 
mode. In particular, we have used Protein 
Interactions Calculator (PIC) to recognize 
the interactions within the bound 
complexes. In structural bioinformatics, 
predicting protein-protein interactions 
which stabilize the tertiary and quaternary 
structures is an important task. For the top 
Inhibitor No of swiss 
doc Clusters  
Full fitness 
(kcalmol)(-) 
Estimated Δ G 
(kcalmol) (-) 
 
Cluster rank 
Jensenone 38 2290.07 6.03 0 0 
  2290.06 6.02 0 1 
  2290.02 6.01 0 2 
  2289.93 6.00 0 3 
  2289.92 5.93 0 4 
  2289.74 5.91 0 5 
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best four Mpro/ Jensenone complexes with 
the best cluster size were subjected to PIC 
server and the binding mode (interactions) 
of each peptide are given in Table 2. PIC 
identified interactions such as hydrophobic 
residues interactions, ionic interactions, 
hydrogen bonds, aromatic-aromatic 
interactions and aromatic–sulphur 
interactions within the peptide-protein 
complexes. According to the PIC server 
results as shown in Table 4, Mpro/ 
Jensenone complexes forms hydrophobic 
interactions with 
ALA7,PRO52,TRP207,LEU29,TRY126, 
PRO184; hydrogen bond interactions with 
M4,V18,L30,D10,T16; and ionic interactions 
with LYS3,ASP34,ARG38,HIS163 as shown 
in Table 4. These residues may be 
considered as key or critical and may play a 
major role in the protein protein-interaction 
and might inhibit the formation of the beta-
barrel motif of Mpro/3CLpro. Further 
studies may help to understand the role of 
these residues in drug binding mechanism.  
Structural flexibility is one of the important 
physical properties that affect protein 
conformation and function. Whereas high 
increase in kinetics energy and protein 
flexibility can disrupt non covalent 
interactions as in thermal denaturation; a 
sharp decrease in flexibility can also cause 
protein denaturation as seen in cold 
denaturation. Therefore, proteins need an 
essential amount of flexibility to carry out 
their native function at physiological 
conditions. In this context, an inhibitor by 
binding to a protein can alter its flexibility 
and decrease its enzymatic activity. Finally, 
lack of wet-lab validation is a drawback in 
our research and we expect computational 
biology analysis and its integration with 
wet-lab data can be productive in the 
determination of potential anti-
Mpro/3CLpro components. 
 
Table 4:  Binding mode of each peptide-protein complex using Protein Interaction 
Calculator (PIC) server. 
Hydrophobic 
interactions 
Main chain 
Hydrogen 
bond 
interactions 
Main chain-
Side chain 
Hydrogen 
bond 
interactions 
Side chain-
Side chain 
Hydrogen 
bond 
interactions 
Intra 
protein 
Ionic 
interactions 
Aromatic 
aromatic 
interactions 
Aromatic 
sulphur 
interactions 
Intraprotein 
Cation-Pi 
Interactions 
PRO7 
PHE9 
VAL13 
LEU73 
TYR103 
M4 
G13 
V16 
F228 
N236 
PHE6 
ASN26 
HIS78 
Ser8 
ARG38 
SER63 
CYS143 
LYS3 
ASP34 
ARG38 
HIS163 
PHE1 
TYR35 
TRP216 
TYR54 
TYP207 
PHE1 
TYR35 
TYP216 
 
 
Conclusion 
Due to non approved drugs at present 
Currently, COVID-19 has emerged in the 
human population, in China, and is a 
potential threat to global health, worldwide. 
Currently, the main target for COVID-19 
treatment primarily act on the main protease 
(Mpro). The aim of this study was to 
examine Jensenone from eucalyptus 
essential oil that may be used to inhibit the 
COVID-19 infection pathway. Jensenone has 
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high binding affinity and  lowest binding 
energies. Therefore, we suggested that may 
Jensenone may represent potential treatment 
options, and found in medicinal plants that 
may act as potential inhibitors of COVID-19 
Mpro. However, further studies should be 
conducted for the validation of these 
compounds using in vitro and in vivo 
models to pave a way for these compounds 
in drug discovery. 
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